Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 11, 2007

deCODE Biostructures and InterMune Expand Screening Collaboration

  • deCODE biostructures initiated a third research project with InterMune. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target. The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »